Antiviral Drugs

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

Evaluation of Tenofovir Disoproxil Fumarate Treatment in Patients with Chronic Hepatitis B

Petek Konya and Neşe Demirtürk

Chronic hepatitis B (CHB) is one of the major causes of chronic liver diseases worldwide. Around 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year and more than 820 thousand people losing their life because of hepatitis B virus (HBV) related complications. Chronic HBV (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir

İsmail Çelik and others

Since its emergence in December 2019, 530,266,292 confirmed coronavirus disease 2019 (COVID-19) cases, including 6,299,364 deaths were reported as of June 7, 2022. It’s widely accepted that in older age, comorbidities (hypertension, diabetes mellitus, obesity, chronic respiratory disease, (...) Read More